Cargando…
Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia
BACKGROUND: Until now, the coronavirus disease 2019 (COVID-19) pandemic has affected more than 2.5 million individuals worldwide, with approximately 170,000 deaths. Currently, no treatments with robust evidence of clinical benefit exist, and utilization of experimental agents have been recommended b...
Autores principales: | Suna, Kavurgacı, Melahat, Uzel Şener, Murat, Yıldız, Figen, Öztürk Ergür, Ayperi, Öztürk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109827/ https://www.ncbi.nlm.nih.gov/pubmed/35601360 http://dx.doi.org/10.1016/j.medcle.2021.04.027 |
Ejemplares similares
-
Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia
por: Suna, Kavurgacı, et al.
Publicado: (2022) -
Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study
por: Ergür, Figen Öztürk, et al.
Publicado: (2022) -
Highlights of clinical and laboratory parameters among severe COVID-19 patients treated with tocilizumab: a retrospective observational study
por: Şener, Melahat Uzel, et al.
Publicado: (2022) -
An unusual, life-threatening complication of EBUS-TBNA: Pneumoperitoneum
por: Söyler, Yasemin, et al.
Publicado: (2023) -
Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia
por: Yildirim, Fatma, et al.
Publicado: (2022)